CYCN - Cyclerion Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
Total Revenue
5,521
4,507
0
0
Operating Expense
115,879
129,544
115,252
93,922
Operating Income
-110,358
-125,037
-115,252
-93,922
Net Non Operating Interest Income Expense
2,390
2,029
-
-
Pretax Income
-105,855
-123,008
-115,252
-93,922
Net Income Common Stockholders
-105,855
-123,008
-115,561
-93,922
Diluted NI Available to Com Stockholders
-105,855
-123,008
-115,561
-93,922
Basic EPS
-
-
-0.0042
-0.0034
Diluted EPS
-
-
-0.0042
-0.0034
Basic Average Shares
-
-
27,304
27,304
Diluted Average Shares
-
-
27,304
27,304
Total Operating Income as Reported
-108,245
-125,037
-115,252
-93,922
Total Expenses
115,879
129,544
115,252
93,922
Net Income from Continuing & Discontinued Operation
-105,855
-123,008
-115,252
-93,922
Normalized Income
-105,855
-123,008
-115,252
-93,922
Interest Income
2,390
2,029
-
-
Net Interest Income
2,390
2,029
-
-
EBIT
-110,358
-125,037
-115,252
-93,922
EBITDA
-107,557
-
-
-
Reconciled Depreciation
2,801
2,700
1,528
1,745
Net Income from Continuing Operation Net Minority Interest
-105,855
-123,008
-115,252
-93,922
Normalized EBITDA
-107,557
-122,337
-113,724
-92,177
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0